These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31576137)

  • 121. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma.
    Teo MY; Bambury RM; Zabor EC; Jordan E; Al-Ahmadie H; Boyd ME; Bouvier N; Mullane SA; Cha EK; Roper N; Ostrovnaya I; Hyman DM; Bochner BH; Arcila ME; Solit DB; Berger MF; Bajorin DF; Bellmunt J; Iyer G; Rosenberg JE
    Clin Cancer Res; 2017 Jul; 23(14):3610-3618. PubMed ID: 28137924
    [No Abstract]   [Full Text] [Related]  

  • 122. DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.
    Nemec AA; Abriola L; Merkel JS; de Stanchina E; DeVeaux M; Zelterman D; Glazer PM; Sweasy JB
    Mol Cancer Res; 2017 Mar; 15(3):269-280. PubMed ID: 28074003
    [TBL] [Abstract][Full Text] [Related]  

  • 123. The host STING pathway at the interface of cancer and immunity.
    Corrales L; McWhirter SM; Dubensky TW; Gajewski TF
    J Clin Invest; 2016 Jul; 126(7):2404-11. PubMed ID: 27367184
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
    Mbeutcha A; Rouprêt M; Kamat AM; Karakiewicz PI; Lawrentschuk N; Novara G; Raman JD; Seitz C; Xylinas E; Shariat SF
    World J Urol; 2017 Mar; 35(3):337-353. PubMed ID: 27101100
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
    Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
    Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J
    Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367
    [TBL] [Abstract][Full Text] [Related]  

  • 127. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
    Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
    J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
    [TBL] [Abstract][Full Text] [Related]  

  • 128. The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology.
    Kan G; Dong W
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3063-71. PubMed ID: 26367730
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Type I interferons in anticancer immunity.
    Zitvogel L; Galluzzi L; Kepp O; Smyth MJ; Kroemer G
    Nat Rev Immunol; 2015 Jul; 15(7):405-14. PubMed ID: 26027717
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer.
    Qing Y; Li Q; Ren T; Xia W; Peng Y; Liu GL; Luo H; Yang YX; Dai XY; Zhou SF; Wang D
    Drug Des Devel Ther; 2015; 9():901-9. PubMed ID: 25733810
    [TBL] [Abstract][Full Text] [Related]  

  • 131. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
    Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
    Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
    [TBL] [Abstract][Full Text] [Related]  

  • 132. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
    Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
    Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
    [TBL] [Abstract][Full Text] [Related]  

  • 133. DNA damage and innate immunity: links and trade-offs.
    Chatzinikolaou G; Karakasilioti I; Garinis GA
    Trends Immunol; 2014 Sep; 35(9):429-35. PubMed ID: 25023467
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Interferon regulatory factor 3 in adaptive immune responses.
    Ysebrant de Lendonck L; Martinet V; Goriely S
    Cell Mol Life Sci; 2014 Oct; 71(20):3873-83. PubMed ID: 24879293
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Base excision repair: a critical player in many games.
    Wallace SS
    DNA Repair (Amst); 2014 Jul; 19():14-26. PubMed ID: 24780558
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Human apurinic/apyrimidinic endonuclease 1.
    Li M; Wilson DM
    Antioxid Redox Signal; 2014 Feb; 20(4):678-707. PubMed ID: 23834463
    [TBL] [Abstract][Full Text] [Related]  

  • 137. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING.
    Ablasser A; Goldeck M; Cavlar T; Deimling T; Witte G; Röhl I; Hopfner KP; Ludwig J; Hornung V
    Nature; 2013 Jun; 498(7454):380-4. PubMed ID: 23722158
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.
    Sun L; Wu J; Du F; Chen X; Chen ZJ
    Science; 2013 Feb; 339(6121):786-91. PubMed ID: 23258413
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA.
    Wu J; Sun L; Chen X; Du F; Shi H; Chen C; Chen ZJ
    Science; 2013 Feb; 339(6121):826-30. PubMed ID: 23258412
    [TBL] [Abstract][Full Text] [Related]  

  • 140. A germline polymorphism of DNA polymerase beta induces genomic instability and cellular transformation.
    Yamtich J; Nemec AA; Keh A; Sweasy JB
    PLoS Genet; 2012; 8(11):e1003052. PubMed ID: 23144635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.